18/9/2018/US SEC The Securities and Exchange Commission charged a former registered representative with defrauding his brokerage customers – including many elderly retirees and unsophisticated investors – out of more than $2.7 million in a multi-year investment scam. According to the SEC’s complaint, from at least 2014 through 2016, Ernest J. […]
Frauds & Scandals
Biopharmaceutical Company, Executives Charged With Misleading Investors About Cancer Drug
September 18, 2018/US SEC The Securities and Exchange Commission today announced that a Boulder, Colorado-based biopharmaceutical company, its CEO, and its former CFO will pay more than $20 million in penalties to settle charges of misleading investors about the company’s developmental lung cancer drug. The SEC’s complaint filed in federal […]
SEC Files Subpoena Enforcement Action Against John Paul Waymack
September 18, 2018/US SEC The Securities and Exchange Commission has filed a subpoena enforcement action against John Paul Waymack, seeking an order directing him to comply with an investigative subpoena for documents and testimony. According to the application and supporting papers, which were filed in the United States District Court […]
